Revisiting the cardiovascular risk of hydroxychloroquine in RA

Cardiac toxicity can be induced by hydroxychloroquine, especially when used in combination with azithromycin. Interest in hydroxychloroquine and azithromycin as potential therapies for COVID-19 has renewed concerns about the possible cardiovascular risk these drugs present to patients with rheumatoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pers, Yves-Marie, Padern, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
News & Views
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525224/
https://www.ncbi.nlm.nih.gov/pubmed/32999492
http://dx.doi.org/10.1038/s41584-020-00521-x
_version_ 1783588699615789056
author Pers, Yves-Marie
Padern, Guillaume
author_facet Pers, Yves-Marie
Padern, Guillaume
author_sort Pers, Yves-Marie
collection PubMed
description Cardiac toxicity can be induced by hydroxychloroquine, especially when used in combination with azithromycin. Interest in hydroxychloroquine and azithromycin as potential therapies for COVID-19 has renewed concerns about the possible cardiovascular risk these drugs present to patients with rheumatoid arthritis.
format Online
Article
Text
id pubmed-7525224
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-75252242020-09-30 Revisiting the cardiovascular risk of hydroxychloroquine in RA Pers, Yves-Marie Padern, Guillaume Nat Rev Rheumatol News & Views Cardiac toxicity can be induced by hydroxychloroquine, especially when used in combination with azithromycin. Interest in hydroxychloroquine and azithromycin as potential therapies for COVID-19 has renewed concerns about the possible cardiovascular risk these drugs present to patients with rheumatoid arthritis. Nature Publishing Group UK 2020-09-30 2020 /pmc/articles/PMC7525224/ /pubmed/32999492 http://dx.doi.org/10.1038/s41584-020-00521-x Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News & Views
Pers, Yves-Marie
Padern, Guillaume
Revisiting the cardiovascular risk of hydroxychloroquine in RA
title Revisiting the cardiovascular risk of hydroxychloroquine in RA
title_full Revisiting the cardiovascular risk of hydroxychloroquine in RA
title_fullStr Revisiting the cardiovascular risk of hydroxychloroquine in RA
title_full_unstemmed Revisiting the cardiovascular risk of hydroxychloroquine in RA
title_short Revisiting the cardiovascular risk of hydroxychloroquine in RA
title_sort revisiting the cardiovascular risk of hydroxychloroquine in ra
topic News & Views
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525224/
https://www.ncbi.nlm.nih.gov/pubmed/32999492
http://dx.doi.org/10.1038/s41584-020-00521-x
work_keys_str_mv AT persyvesmarie revisitingthecardiovascularriskofhydroxychloroquineinra
AT padernguillaume revisitingthecardiovascularriskofhydroxychloroquineinra

Ejemplares similares